Back
Madrigal Pharmaceuticals Stock Price Chart
America's Final Republican President
Click here to see his 2024 election prediction.
Sell
50
MDGL
Madrigal Pharmaceuticals
Last Price:
211.54
Seasonality Move:
-0.64%
7 Day Trial
ALL ACCESS PASS
$
7
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDGL is experiencing slight selling pressure.
Madrigal Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 216.31 | Sell |
| 20-day SMA: | 214.36 | Sell |
| 50-day SMA: | 237.87 | Sell |
| 200-day SMA: | 201.46 | Buy |
| 8-day EMA: | 212.27 | Sell |
| 20-day EMA: | 217.74 | Sell |
| 50-day EMA: | 226.58 | Sell |
| 200-day EMA: | 215.99 | Sell |
Madrigal Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.87 | Sell |
| Relative Strength Index (14 RSI): | 41.06 | Sell |
| Chaikin Money Flow: | -100722 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Madrigal Pharmaceuticals Technical Analysis
| Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Madrigal Pharmaceuticals Stock
Is Madrigal Pharmaceuticals Stock a Buy?
- Madrigal Pharmaceuticals share price is 205.25 while MDGL 8-day simple moving average is 216.31, which is a Sell signal.
- The stock price of MDGL is 205.25 while Madrigal Pharmaceuticals 20-day SMA is 214.36, which makes it a Sell.
- Madrigal Pharmaceuticals 50-day simple moving average is 237.87 while MDGL share price is 205.25, making it a Sell technically.
- MDGL stock price is 205.25 and Madrigal Pharmaceuticals 200-day simple moving average is 201.46, creating a Buy signal.
MDGL Technical Analysis vs Fundamental Analysis
Sell
50
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals a Buy or a Sell?
-
Madrigal Pharmaceuticals stock is rated a Sell
The current Madrigal Pharmaceuticals [MDGL] share price is $205.25. The Score for MDGL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Madrigal Pharmaceuticals Stock Info
Market Cap:
4.37B
Price in USD:
205.25
Share Volume:
234.06K
Madrigal Pharmaceuticals 52-Week Range
52-Week High:
302.68
52-Week Low:
119.76
Sell
50
Madrigal Pharmaceuticals (MDGL)
is a Sell
Madrigal Pharmaceuticals Share Price Forecast
-
What is the Madrigal Pharmaceuticals stock price today?
The Madrigal Pharmaceuticals stock price is 205.25 USD today. -
Will MDGL stock go up or go down?
Madrigal Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Madrigal Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Madrigal Pharmaceuticals is overvalued.
Is Madrigal Pharmaceuticals Stock a Buy?
- Madrigal Pharmaceuticals share price is 205.25 while MDGL 8-day exponential moving average is 212.27, which is a Sell signal.
- The stock price of MDGL is 205.25 while Madrigal Pharmaceuticals 20-day EMA is 217.74, which makes it a Sell.
- Madrigal Pharmaceuticals 50-day exponential moving average is 226.58 while MDGL share price is 205.25, making it a Sell technically.
- MDGL stock price is 205.25 and Madrigal Pharmaceuticals 200-day simple moving average is 215.99, creating a Sell signal.
Fundamental Analysis of Madrigal Pharmaceuticals
Is Madrigal Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $2.35 per share, an increase next quarter of $1.27 per share, a decrease this year of $9.09 per share, and an increase next year of $10.64 per share.
Technical Analysis of Madrigal Pharmaceuticals
Should I short Madrigal Pharmaceuticals stock?
- MDGL Moving Average Covergence Divergence (MACD) indicator is -6.87, suggesting Madrigal Pharmaceuticals is a Sell
- Madrigal Pharmaceuticals Relative Strength Index (RSI) is 41.06, which suggest Madrigal Pharmaceuticals is oversold
- The Bollinger Bands (25) for Madrigal Pharmaceuticals is ( - ), which suggest Madrigal Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Madrigal Pharmaceuticals is ( - ), which suggest Madrigal Pharmaceuticals is a Buy
* Madrigal Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.